- Report
- July 2023
- 110 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- July 2024
- 150 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Report
- February 2025
- 85 Pages
India
From €3053EUR$3,500USD£2,661GBP
- Report
- February 2024
- 115 Pages
Global
From €4143EUR$4,750USD£3,611GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2433EUR$2,789USD£2,120GBP
- Report
- October 2024
- 200 Pages
Global
From €4317EUR$4,949USD£3,762GBP
- Report
- December 2023
- 160 Pages
United States
From €2433EUR$2,789USD£2,120GBP
- Report
- May 2023
- 147 Pages
Global
From €4317EUR$4,949USD£3,762GBP
- Report
- January 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- April 2025
- 80 Pages
Vietnam
From €4230EUR$4,850USD£3,687GBP
- Report
- July 2024
- 326 Pages
China
From €3489EUR$4,000USD£3,041GBP
- Report
- July 2024
- 187 Pages
China
From €1570EUR$1,800USD£1,368GBP
- Report
- November 2023
- 29 Pages
United States
€2181EUR$2,500USD£1,900GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3009EUR$3,450USD£2,623GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2573EUR$2,950USD£2,242GBP
- Report
- September 2023
- 112 Pages
Europe
From €3009EUR$3,450USD£2,623GBP
- Report
- September 2023
- 194 Pages
Global
From €4318EUR$4,950USD£3,763GBP
- Report
- October 2022
- 194 Pages
Global
From €4361EUR$5,000USD£3,801GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,298USD£3,157GBP
- Report
- July 2023
- 84 Pages
Global
From €3500EUR$4,298USD£3,157GBP

The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more